February 08, 2023
AABB has prepared an analysis and comparison of the January 2023 HIV guidance and August 2020 HIV guidance that highlights significant changes between the two documents.
As described during AABB’s Feb. 2 Hot Topic Discussion - Peter Marks Speaks to AABB Community on FDA’s Draft Individual Risk Assessment Guidance, AABB will continue to provide materials and resources to support members through implementation of the final guidance.
Members may visit AABB’s Planning for Transition to Individual Risk Assessment web page for additional updates.